Free Trial

Renaissance Technologies LLC Acquires New Holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Guardian Pharmacy Services logo with Medical background

Renaissance Technologies LLC purchased a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 141,100 shares of the company's stock, valued at approximately $2,859,000. Renaissance Technologies LLC owned 0.22% of Guardian Pharmacy Services at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of GRDN. Franklin Resources Inc. purchased a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $8,575,000. Geode Capital Management LLC purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $4,073,000. Royce & Associates LP boosted its position in shares of Guardian Pharmacy Services by 185.3% in the 4th quarter. Royce & Associates LP now owns 214,000 shares of the company's stock worth $4,336,000 after purchasing an additional 139,000 shares in the last quarter. Russell Investments Group Ltd. boosted its position in shares of Guardian Pharmacy Services by 364.6% in the 4th quarter. Russell Investments Group Ltd. now owns 73,241 shares of the company's stock worth $1,484,000 after purchasing an additional 57,475 shares in the last quarter. Finally, New York State Common Retirement Fund grew its stake in shares of Guardian Pharmacy Services by 17.9% in the 4th quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock worth $5,643,000 after buying an additional 42,368 shares during the last quarter.

Wall Street Analyst Weigh In

Separately, Truist Financial boosted their target price on Guardian Pharmacy Services from $24.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, April 11th.

View Our Latest Stock Report on GRDN

Guardian Pharmacy Services Trading Up 3.7 %

Shares of NYSE:GRDN traded up $0.88 during trading on Wednesday, reaching $24.98. 157,282 shares of the stock traded hands, compared to its average volume of 149,946. The stock has a 50-day moving average of $21.27 and a two-hundred day moving average of $21.15. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $25.87.

Guardian Pharmacy Services Profile

(Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

Institutional Ownership by Quarter for Guardian Pharmacy Services (NYSE:GRDN)

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines